Prime Therapeutics Newsroom

GradientRule_withspacer

David Schlett joins Prime Therapeutics as Chief Financial Officer

Schlett is an experienced finance executive with more than 25 years of business, leadership experience. More about David's role at Prime

GradientRule_withspacer

News from Prime

Mind the gap: Using a drug’s price-to-value calculation

Prime applies a price-to-value framework for high cost drugs. This helps drive a productive dialogue based on the value a drug can deliver to a  a patient’s life. 



Small in number, but large in impact, “drug super spenders” need super attention

Just 0.03 percent of members have annual drug costs over $250,000. They account for 9 percent of total drug spend. 


 

 

 

 

 

 

 

 

 

 

 

 

 

GradientRule_withspacer

Prime Insights

Explore drug research, analyses and insights from Prime's pharmacy experts.

Prime Insights

Get in touch

Connect with one of our media experts to learn more about the latest news and trends in the pharmacy benefit management industry.

Email the newsroom team
Sign-up for regular email updates

      Facebook